跳至主要内容
临床试验/NL-OMON48618
NL-OMON48618已完成不适用

Early clinical and biomarker responses after treatment in patients with non-segmental vitiligo - Early responses in vitiligo

Academisch Medisch Centrum0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with non-segmental vitiligo commencing standard of care treatment,
  • consisting of a potent topical corticosteroid, such as FP cream, alone or in
  • combination with NB-UVB phototherapy for at least 6 months.
  • - Patients with new lesions and/or signs of disease progression (active
  • disease) within the past 6 months prior to Screening.
  • - Males and females aged *18
  • - Patients able to communicate well with the investigator, to understand the
  • requirements of the study, as well as understand and sign the written informed

排除标准

  • - Patients that have received phototherapy or systemic immunosuppressive
  • treatment during the last 6 weeks prior to Screening.
  • - Patients that have received topical anti-inflammatory treatment (topical
  • corticosteroids, calcineurin inhibitors) during the last 4 weeks prior to
  • - Patients currently receiving treatments other than potent topical
  • corticosteroids, such as FP 0.05% cream, calcineurin inhibitors (tacrolimus,
  • pimecrolimus) or NB-UVB phototherapy for non-segmental vitiligo.
  • - Recurrent HSV skin infections.
  • - Patients with a history of hypertrophic scars or keloid.
  • - Patients with a history of hypersensitivity to (UVB or UVA) light and/or
  • allergy to local anaesthesia.
  • - Pregnant or nursing (lactating) women, where pregnancy is defined as the
  • state of a female after conception and until the termination of gestation,
  • confirmed by a positive hCG laboratory test (unless female is confirmed
  • post-menopausal).
  • - Patients with haemophilia or other clotting disorders
  • - Patients previously diagnosed with depression according to the DSM5 by a
  • qualifying physician.
  • - Patients without lesions located at suitable areas for biopsies / suction
  • blisters sampling (e.g. the face)

研究者

相似试验